Pharming Group N.V. Postemployment Benefit Expense Defined Benefit Plans
Pharming Group N.V. (PHAR) reported Postemployment Benefit Expense Defined Benefit Plans of $4.58 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2026-04-02
EUR
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2020-12-31 | 1.61M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 1.58M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 1.03M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2025-12-31 | $4.58M 20-F · filed 2026-04-02 |
| 2024-12-31 | $3.63M 20-F · filed 2026-04-02 |
| 2023-12-31 | $2.98M 20-F · filed 2026-04-02 |
| 2022-12-31 | $2.28M 20-F · filed 2025-04-03 |
| 2021-12-31 | $2.18M 20-F · filed 2024-04-04 |
| 2020-12-31 | $1.84M 20-F · filed 2023-04-05 |
| 2019-12-31 | $1.77M 20-F · filed 2022-04-06 |